7-77355253-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_017439.4(GSAP):c.1298C>T(p.Ala433Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000471 in 1,613,842 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_017439.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GSAP | NM_017439.4 | c.1298C>T | p.Ala433Val | missense_variant | 16/31 | ENST00000257626.12 | NP_059135.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GSAP | ENST00000257626.12 | c.1298C>T | p.Ala433Val | missense_variant | 16/31 | 1 | NM_017439.4 | ENSP00000257626.7 | ||
GSAP | ENST00000334003.11 | n.1189C>T | non_coding_transcript_exon_variant | 15/19 | 2 | |||||
GSAP | ENST00000434084.1 | n.32C>T | non_coding_transcript_exon_variant | 1/4 | 3 | |||||
GSAP | ENST00000449779.5 | n.254C>T | non_coding_transcript_exon_variant | 2/16 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152166Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000840 AC: 21AN: 249998Hom.: 0 AF XY: 0.0000666 AC XY: 9AN XY: 135208
GnomAD4 exome AF: 0.0000486 AC: 71AN: 1461558Hom.: 0 Cov.: 30 AF XY: 0.0000495 AC XY: 36AN XY: 727090
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152284Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74478
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 19, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at